These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4469696)

  • 1. Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid.
    Kroll WA; Schneider JA
    Science; 1974 Dec; 186(4168):1040-2. PubMed ID: 4469696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors controlling the nonprotein cystine content of cystinotic fibroblasts.
    Crawhall JC; Oshima RG; Schneider JA
    Pediatr Res; 1977 Jan; 11(1 Pt 1):41-5. PubMed ID: 831218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystinotic and normal fibroblasts: differential protection in cystine-free medium by dithiothreitol.
    Lancaster GA; Scriver CR
    Pediatr Res; 1982 Jan; 16(1):86-8. PubMed ID: 7070882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of cystine in cystinotic fibroblasts by homocysteine. Synergism of cysteamine with various reducing agents in depletion of cystine from cystinotic fibroblasts.
    Butler JD
    Biochem Pharmacol; 1990 Aug; 40(4):879-85. PubMed ID: 2386552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of mercaptoethylgluconamide for depleting human cystinotic fibroblasts of their accumulated lysosomal cystine.
    Pisoni RL; Lisowski KM; Lemons RM; Thoene JG
    Pediatr Res; 1989 Jul; 26(1):73-6. PubMed ID: 2771512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the intracellular cystine content of cystinotic fibroblasts by extracellular albumin.
    Thoene JG; Lemons R
    Pediatr Res; 1980 Jun; 14(6):785-7. PubMed ID: 7402752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystine accumulation and loss in normal, heterozygous, and cystinotic fibroblasts.
    Jonas AJ; Greene AA; Smith ML; Schneider JA
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4442-5. PubMed ID: 6956872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selenium compounds on selenium content, growth and 35S-cystine metabolism of skin fibroblasts from normal and cystinotic individuals.
    Rhead WJ; Schneider JA
    Bioinorg Chem; 1976; 6(3):187-202. PubMed ID: 1053514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of intracellular cystine content in cystinotic fibroblasts by inhibitors of gamma-glutamyl transpeptidase.
    Butler JD; Spielberg SP
    J Biol Chem; 1981 May; 256(9):4160-3. PubMed ID: 6111562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid treatment in nephropathic cystinosis in identical twins.
    Oberfield SE; Levine LS; Wellner D; Novogroder M; Laino P; New MI
    Dev Pharmacol Ther; 1981; 2(2):80-90. PubMed ID: 7472109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased free-cystine content of fibroblasts cultured from patients with cystinosis.
    Schneider JA; Rosenbloom FM; Bradley KH; Seegmiller JE
    Biochem Biophys Res Commun; 1967 Nov; 29(4):527-31. PubMed ID: 16496530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal cystine storage in cystinosis and mucolipidosis type II.
    Greene AA; Jonas AJ; Harms E; Smith ML; Pellett OL; Bump EA; Miller AL; Schneider JA
    Pediatr Res; 1985 Nov; 19(11):1170-4. PubMed ID: 4069825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystine accumulation and clearance in normal and cystinotic fibroblasts exposed to cystine dimethyl ester.
    Steinherz R; Makov N; Narinsky R; Meidan B; Kohn G
    Clin Chim Acta; 1984 Aug; 141(2-3):119-25. PubMed ID: 6488551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystine storage in cultured myotubes from patients with nephropathic cystinosis.
    Harper GS; Bernardini I; Hurko O; Zuurveld J; Gahl WA
    Biochem J; 1987 May; 243(3):841-5. PubMed ID: 3663103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystinosis and its therapy.
    Segal S
    N Engl J Med; 1979 Apr; 300(14):789-90. PubMed ID: 423913
    [No Abstract]   [Full Text] [Related]  

  • 16. Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.
    Schneider JA; Schlesselman JJ; Mendoza SA; Orloff S; Thoene JG; Kroll WA; Godfrey AD; Schulman JD
    N Engl J Med; 1979 Apr; 300(14):756-9. PubMed ID: 370586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered status of glutathione and its metabolites in cystinotic cells.
    Levtchenko E; de Graaf-Hess A; Wilmer M; van den Heuvel L; Monnens L; Blom H
    Nephrol Dial Transplant; 2005 Sep; 20(9):1828-32. PubMed ID: 15956064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo use of dithiothreitol in cystinosis.
    Depape-Brigger D; Goldman H; Scriver CR; Delvin E; Mamer O
    Pediatr Res; 1977 Feb; 11(2):124-31. PubMed ID: 840501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of decreased growth temperature on the cystine content of cystinotic fibroblasts.
    Forster S; Scarlett L; Lloyd JB
    Biochim Biophys Acta; 1989 Sep; 1013(1):7-10. PubMed ID: 2790040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated temperature produces cystine depletion in cystinotic fibroblasts.
    Lemons RM; Pisoni RL; Christensen HN; Thoene JG
    Biochim Biophys Acta; 1986 Dec; 884(3):429-34. PubMed ID: 3778933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.